ChemoCentryx falls on the FDA committee's lukewarm support and analysts' downgrades.ChemoCentryx falls on the FDA committee's lukewarm support and analysts' downgrades.ChemoCentryx (CCXI) - Get Reportplummeted by record levels Friday after a regulatory panel gave mixed support to the biotech'...

https://www.thestreet.com/investing/chemocentrynx-nosedives-on-split-fda-panel-decision

#thestreet